Human chorionic gonadotropin measurements in parathyroid carcinoma

European Journal of Endocrinology

Volumn 159, Issue 4, 2008, Pages 469-474

  Rubin, Mishaela R ^a   Bilezikian, John P ^a   Birken, Steven ^a   Silverberg, Shonni J ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CINACALCET; TUMOR MARKER; CALCIUM; NAPHTHALENE DERIVATIVE; PARATHYROID HORMONE;

ADULT; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE ESCALATION; FATALITY; FEMALE; GONADOTROPIN RELEASE; HIP FRACTURE; HUMAN; MALE; MORNING DOSAGE; OBSERVATIONAL STUDY; PARATHYROID CARCINOMA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN GLYCOSYLATION; URINALYSIS; AGED; BLOOD; HYPERPARATHYROIDISM; METABOLISM; MIDDLE AGED; PARATHYROID TUMOR; URINE;

AGED; CALCIUM; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 54049150780     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0169     Document Type: Article

References (29)

1. Shane E. Clinical review 122: parathyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2001 86 485-493.
2. Obara T & Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World Journal of Surgery 1991 15 738-744.
3. Lumachi F, Basso SM & Basso U. Parathyroid cancer: etiology, clinical presentation and treatment. Anticancer Research 2006 26 4903-4807.
4. Lee PK, Jarosek SL, Virnig BA, Evasovich M & Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 2007 109 1736-1741.
5. Wang CA & Gaz RD. Natural history of parathyroid carcinoma. Diagnosis, treatment, and results. American Journal of Surgery 1985 149 522-527.
6. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C & Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. New England Journal of Medicine 2003 349 1722-1729.
7. Stenman UH, Alfthan H & Hotakainen K. Human chorionic gonadotropin in cancer. Clinical Biochemistry 2004 37 549-561.
8. Khanlian SA, Smith HO & Cole LA. Persistent low levels of human chorionic gonadotropin: a premalignant gestational trophoblastic disease. American Journal of Obstetrics and Gynecology 2003 188 1254-1259.
9. Birken S. Specific measurement of o-linked core 2 sugar-containing isoforms of hyperglycosylated human chorionic gonadotropin by antibody b152. Tumour Biology 2005 26 131-141.
10. Birken S, Krichevsky A, O'Connor J, Schlatterer J, Cole L, Kardana A & Canfield R. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 1999 10 137-144.
11. Kovalevskaya G, Birken S, Kakuma T & O'Connor JF. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. Journal of Endocrinology 1999 161 99-106.
12. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, Sturgeon C & Stenman UH. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clinical Chemistry 2003 49 144-154.
13. Krichevsky A, Birken S, O'Connor J, Acevedo HF, Bikel K, Lustbader J, Hartree A & Canfield RE. Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG. Endocrinology 1994 134 1139-1145.
14. Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, Cohen M, Kelly A, Schlatterer J & O'Connor JE Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. Journal of Endocrinology 2002 172 497-506.
15. Pandian R, Lu J & Ossolinska-Plewnia J. Fully automated chemiluminometric assay for hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen). Clinical Chemistry 2003 49 808-810.
16. Wurzel RS, Yamase HT & Nieh PT. Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract. Journal of Urology 1987 137 502-504.
17. Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H & Stenman UH. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. British Journal of Cancer 2002 86 185-189.
18. Shah VM, Newman J, Crocker J, Antonakopoulos GN, Chapple CR & Collard MJ. Production of beta-human chorionic gonadotropin by prostatic adenocarcinoma and transitional cell carcinoma of the upper urinary tract. British Journal of Experimental Pathology 1987 68 871-878.
19. Alfthan H, Haglund C, Roberts P & Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Research 1992 52 4628-4633.
20. Grossmann M, Trautmann ME, Poertl S, Hoermann R, Berger P, Arnold R & Mann K. Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours. European Journal of Clinical Investigation 1994 24 131-136.
21. Bepler G, Jaques G, Oie HK & Gazdar AF. Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. Cancer Letters 1991 58 145-150.
22. Agnantis NJ, Patra F, Khaldi L & Filis S. Immunohistochemical expression of subunit beta HCG in breast cancer. European Journal of Gynaecological Oncology 1992 13 461-466.
23. Braunstein GD, Vaitukaitis JL, Carbone PP & Ross GT. Ectopic production of human chorionic gonadotrophin by neoplasms. Annals of Internal Medicine 1973 78 39-45.
24. Bhalang K, Kafrawy AH & Miles DA. Immunohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma. Cancer 1999 85 757-762.
25. Acevedo HE Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ & Hartsock RJ. Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 1992 69 1829-1842.
26. Butler SA, Ikram MS, Mathieu S & Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. British Journal of Cancer 2000 82 1553-1556.
27. Stock JL, Weintraub BD, Rosen SW, Aurbach GD, Spiegel AM & Marx SJ. Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1982 54 57-63.
28. Carlinfante G, Lampugnani R, Azzoni C, Aprile MR, Brandi ML & Bordi C. Expression of the alpha- and beta-subunits of human chorionic gonadotropin by subsets of parathyroid cells in states of hyperparathyroidism. Journal of Pathology 1998 185 389-393.
29. Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P & Bilezikian JP. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2007 92 3803-3808.